T1 200 (Carbidopa, entacapone and levodopa 50 mg / 200 mg / 200 mg)
Pill imprint T1 200 has been identified as Carbidopa, entacapone and levodopa 50 mg / 200 mg / 200 mg.
Carbidopa/entacapone/levodopa is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/entacapone/levodopa 50 mg / 200 mg / 200 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- T1 200
- Strength:
- 50 mg / 200 mg / 200 mg
- Color:
- Red
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Sun Pharma Global FZE
- National Drug Code (NDC):
- 47335-0006
- Inactive Ingredients:
- corn starch
croscarmellose sodium
glycerin
hypromelloses
magnesium stearate
mannitol
polysorbate 80
povidone
sucrose
ferric oxide red
titanium dioxide
More about carbidopa/entacapone/levodopa
Consumer resources
- Carbidopa/entacapone/levodopa
- Carbidopa/levodopa/entacapone
- Carbidopa, entacapone, and levodopa
- Carbidopa, entacapone, and levodopa (Advanced Reading)
- Other brands: Stalevo, Stalevo 100, Stalevo 200, Stalevo 50, More (3) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
